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Summary
Objective: Cytokines produced by inflammatory cells play a pivotal role in synovial inflammation and joint destruction in rheumatoid arthritis.
To investigate the influence of pro-inflammatory cytokines (IL-1α, IL-6, TNF-α, IFN-γ) and subsequently the possible beneficial role of an
anti-inflammatory cytokine (IL-4) on chondrocyte viability (necrosis/apoptosis), proliferation and nitric oxide (NO) production.
Methods: Primary bovine chondrocytes were cultured until monolayers were obtained. Cells were incubated with cytokines (IL-1α, IFN-γ,
TNF-α, IL-4, IL-6) at 0.1, 1, 10 and 100 ng/mL. After 48 h, the viability of the chondrocytes was measured flow cytometrically with propidium
iodide. Proliferation was determined by the incorporation of tritiated thymidine. The morphology of the chondrocytes, including presence of
apoptotic nuclei, was evaluated by a May-Gru¨nwald–Giemsa staining. In addition, the number of apoptotic chondrocytes was detected flow
cytometrically with a TUNEL technique and annexin-V/propidium iodide staining. NO production was evaluated using a spectrophotometric
assay, based upon the Griess reaction.
Results: The viability and proliferation of bovine chondrocytes decreased after incubation with 100 ng/mL IL-1α, TNF-α or IFN-γ. In contrast,
incubation of chondrocytes with IL-4 or IL-6 had no influence on the viability or the proliferation of cells. IL-1α was able to enhance NO
production in a dose dependent manner. IFN-γ and TNF-α induced NO production only at the highest concentration (100 ng/mL), whereas
IL-4 and IL-6 did not. There was a dose dependent increase in apoptosis of bovine chondrocytes cultured in the presence of IL-1α and
TNF-α. This effect could not be prevented by preincubation with IL-4. Preincubation with IL-4 diminished IL-1α and TNF-α induced NO
production and increased proliferation of chondrocytes. In an additional experiment, incubation of human chondrocytes with anti-Fas did not
induce apoptosis as measured by annexin-V/propidium iodide staining.
Conclusions: Pro-inflammatory cytokines are able to induce apoptosis, whereas IL-4 as an anti-inflammatory cytokine can inhibit the effect
of IL-1α and TNF-α on NO production and proliferation of bovine chondrocytes.
© 2003 Published by Elsevier Ltd on behalf of OsteoArthritis Research Society International.
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Introduction
Rheumatoid arthritis (RA) is a chronic autoimmune disease
characterized by the accumulation of inflammatory cells
into the synovium and the erosion of articular cartilage and
subchondral bone, resulting in severe joint destruction.
Cytokines produced by inflammatory cells play a pivotal
role in synovial inflammation and joint destruction in RA1.
Changes in chondrocyte survival (cell proliferation/death/
apoptosis), induced by pro-inflammatory cytokines, may be
of pathogenetic significance in the development of cartilage
degradation in RA. On the other hand, anti-inflammatory
cytokines, such as IL-4, could inhibit cartilage destruction
by reducing production of pro-inflammatory cytokines by
upregulating cytokine inhibitors and scavenging recep-
tors2,3. In the present study, the direct influence of
pro-inflammatory (IL-1α, IL-6, tumor necrosis factor α
(TNF-α), IFN-γ) and anti-inflammatory (IL-4) cytokines on
chondrocyte viability, proliferation and nitric oxide (NO)
production was investigated.
Methods
CULTURE OF PRIMARY CHONDROCYTES
Bovine articular chondrocytes were obtained from
the tarsometatarsal joint, immediately after slaughter.
Chondrocytes were isolated using hyaluronidase (Roche,
Germany), protease (Sigma, St Louis, USA) and colla-
genase type 1A (Sigma) as described before4. Primary
isolated chondrocytes were cultured in monolayer at
1×106 cells/mL in DMEM with 10% fetal bovine serum
(FBS; Hyclone, UT, USA)4–8 on slide chambers (Flexiperm
micro 12, In Vitro Systems and Services, Osterode,
Germany) for light microscopy and on flat bottom 24 well
plates (Costar, Corning, NY, USA) for flow cytometrical
experiments and on flat bottom 96 well plates for prolifer-
ation and NO assay. Dedifferentiation of primary chondro-
cytes was checked by S-100 and collagen II staining9.
Normal human articular chondrocytes were obtained
from the femoral head of a 48-year-old organ donor without
any history of joint disease, 8 h after death from a lethal
trauma. Osteoarthritic human chondrocytes were obtained
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from two patients (72 and 77 years old) who were under-
going joint replacement surgery. Chondrocytes were iso-
lated and cultured as described above, except that
treatment with collagenase type 1A was prolonged for 12 h.
INCUBATION OF PRIMARY BOVINE CHONDROCYTES WITH
CYTOKINES
After 72 h of culture, bovine chondrocytes were washed
and incubated for 48 h with either pro- or anti-inflammatory
recombinant cytokines at different concentrations (0.1, 1,
10 and 100 ng/mL) in DMEM 10% FBS: human IL-1α
(PeproTech House, London, UK), human TNF-α (Pepro-
Tech House), human IL-6 (PromoCell Gmbh, Heidelberg,
Germany), human IL-4 (PeproTech House) and bovine
IFN-γ (kindly provided by Novartis Animal Health Inc, Basel,
Switzerland). After culture, cells were gently removed from
the 24 well culture plates with a rubber policeman and
washed with PBS before flow cytometric experiment.
PREINCUBATION OF PRIMARY CHONDROCYTES WITH IL-4
Bovine chondrocytes were preincubated with 100 ng/mL
IL-4 in DMEM 10% FBS for 24 h. Thereafter, chondrocytes
were washed with DMEM 10% FBS. Further co-incubation
with 100 ng/mL IL-4, and IL-1α and TNF-α at different
concentrations (0.1, 1, 10, 100 ng/mL) in DMEM 10% FCS
was performed for 48 h.
Human chondrocytes were washed with DMEM and
preincubated with 100 ng/mL IL-4 after 5 days of culture.
After 24 h, IL-1β (PeproTech House) and TNF-α (10 ng/mL)
were added for another 48 h. Thereafter, the NO production
was evaluated using the Griess reaction.
For FAS-induced apoptosis, human chondrocytes were
pretreated with 100 ng/mL IL-4 for 24 h. After preincubation
with IL-4, chondrocytes were incubated for 12 h with
1 µg/mL anti-FAS antibody (CH-11-clone) (MBL, LTD,
Nagoya, Japan)10. Apoptosis was evaluated using annexin-
V/propidium iodide (PI) staining.
VIABILITY OF CHONDROCYTES
Chondrocytes were incubated for 5 min with 50 µg/mL PI
(Sigma). Ten thousand cells were measured on a flow
cytometer (FACScan, BD, USA) and analyzed with WinMDI
software. PI positive cells were considered as non-viable
cells. Results were expressed as percentage viable PI
negative cells.
CHONDROCYTE PROLIFERATION
Chondrocyte proliferation was determined using a tritium
labeled thymidine incorporation method4. During the final
24 h of culture with cytokines, 100 000 chondrocytes
were pulsed with 20 µL methyl-3H thymidine (20 µCi/well,
specific activity 25 Ci/nmol, Amersham Life Sciences,
Amersham, UK). Subsequently, cells were harvested
on glass fiber paper (GF/C-Unifilter, Canberra Packard
Instruments, Meriden, CT, USA), using an automatic cell
harvester (Filtermate 186, Canberra Packard Instruments).
The incorporated radioactivity was measured with a
liquid scintillation counter (Topcount, Canberra Packard
Instruments). All experiments were done in quadruplet.
Results were expressed as counts per minute (cpm).
NO PRODUCTION
The culture supernatant of 100 000 culture chondrocytes
was aspirated and stored at −20°C until assayed. NO
production was measured as nitrite, using a spectrophoto-
metric assay, based upon the Griess assay5. Results were
expressed as µmol/L nitrite.
APOPTOSIS OF CHONDROCYTES
Light microscopy
The chondrocytes were stained with May-Gru¨nwald–
Giemsa (MGG) stain (Auto-Hemacolor, Merck). Two hun-
dred cells were analyzed and scored as apoptotic if clear
nuclear condensation and/or fragmentation (apoptotic
bodies) were present. Results were expressed as percent-
age apoptotic cells. In preliminary experiments, inter- and
intra-observer variability were ±1 and ±4%.
Annexin-V staining
The cells were resuspended in 100 µL HEPES buffer
(Life Technologies), containing 140 mM NaCl2, 2.5 mM
CaCl2 and stained with 5 µL annexin-V–FITC (Pharmingen,
San Diego, CA, USA) and 10 µL PI (50 µg/ml) for 15 min at
room temperature in the dark. After incubation, 100 µL
HEPES buffer was added. Five thousand cells were
measured on a FACScan flow cytometer and analyzed with
WinMDI software. Results were expressed as percentage
(PI negative and annexin-V positive) apoptotic cells.
End labeling of fragmented DNA (TUNEL)
The cells were fixed with 1% paraformaldehyde (Merck)
in PBS. After washing with PBS, cells were fixed in 70%
ethanol (Merck) at −20°C for 1 h. Subsequently, a two color
staining method for labeling DNA breaks in order to detect
apoptotic cells was performed, using Apo BrdU™ Kit
(Pharmingen), according to manufacturer’s instructions.
Briefly, DNA was end-labeled with bromolated deoxyuridine
triphosphates (Br-dUTP), using terminal deoxynucleotidyl
transferase (TdT) and was detected by FITC labeled anti-
BrdU antibodies. After staining for DNA breaks, PI/RNase
was added to stain DNA in the cells in order to gate
normoploid and hypoploid cells. Five thousand cells were
measured on a FACScan flow cytometer and analyzed with
WinMDI software. Results were expressed as percentage
(TUNEL positive) apoptotic cells.
STATISTICS
ANOVA test and paired student’s t-test were per-
formed to analyze differences between samples. A P-
value of <0.05 was considered as significant. Results are
represented as mean±standard error of the mean (S.E.M.).
Results
CHONDROCYTE INCUBATION WITH CYTOKINES
Viability
The viability of chondrocytes was significantly diminished
in chondrocytes incubated with 100 ng/mL IL-1α, 64±4%
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(mean±S.E.M.), and slightly decreased when incubated with
100 ng/mL TNF-α or IFN-γ (72±2, 78±1%, respectively),
compared to control chondrocytes 85±3% (P0.002; P
0.02; P0.05). Chondrocytes incubated with IL-4 or IL-6
did not show any difference in viability.
Apoptosis
Quantitative results of percentage apoptotic cells were
obtained by annexin-V/PI and TUNEL assays. To verify and
confirm these quantitative data, microscopic analysis of
chondrocytes with MGG staining was performed: clear
condensation of the nuclei was considered as apoptotic
chondrocytes.
Incubation of chondrocytes with IL-4 or IL-6 at different
concentrations ranging from 0.1 to 100 ng/mL did not
induce apoptosis of chondrocytes, measured by annexin-
V/PI [Fig. 1(a)], TUNEL assay [Fig. 1(b)] and light
microscopy (MGG).
In contrast with these observations, chondrocyte staining
with MGG showed apoptotic bovine chondrocytes (conden-
sation of the nuclei) [Fig. 2(a and b)] when incubated with
100 ng/mL IL-1α (15±3%), TNF-α (18±2%) and IFN-γ
(6±4%), compared to the control chondrocytes (1±1%).
Quantitative results of percentage apoptotic cells were
obtained with annexin-V/PI and TUNEL assays. The
number of apoptotic chondrocytes, measured by TUNEL
technique, was dose dependent up to 17±1% for IL-1α
stimulated cultures and up to 24±7% for TNF-α cultures,
compared to 2±1% in control chondrocytes (P<0.05) [Fig.
1(b)]. Only the highest concentration of IFN-γ (100 ng/mL)
could slightly induce apoptosis in chondrocytes (9±3%,
P0.04) [Fig. 1(b)]. In an additional experiment, incubation
of human chondrocytes with anti-Fas did not induce
apoptosis as measured with annexin-V/PI staining.
Proliferation
Bovine chondrocyte proliferation was inhibited by adding
IL-1α, TNF-α and IFN γ, especially in the highest concen-
trations (10 and 100 ng/mL), compared to control cells
(P0.001; P0.02; P0.05) [Fig. 1(c)]. In contrast, incu-
bation of chondrocytes with IL-4 or IL-6 did not change
the proliferation of chondrocytes, compared to control
chondrocytes [Fig. 1(c)].
NO production
NO production by chondrocytes stimulated with lL-1α
was significantly increased in a dose dependent manner,
compared to control chondrocytes (respectively, P0.04;
P0.01; P0.001 and P0.001) [Fig. 1(d)]. There was a
Fig. 1. Apoptosis, proliferation and NO production of chondrocytes incubated for 48 h with different cytokines: with IL-1α (M), TNF-α (j),
IFN-γ (n), IL-4 (,) or IL-6 (.). Untreated chondrocytes incubated in culture medium without cytokines are represented as 0 ng/mL.
(a) Percentage of annexin-V positive, PI negative apoptotic cells. (b) Percentage of TUNEL positive apoptotic cells. (c) Proliferation of cells,
measured as counts per minute (cpm). (d) µmol/L NO, measured by Griess reaction. Results are expressed as mean (±S.E.M.) of three
experiments. *P<0.05 vs control chondrocytes.
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positive correlation between IL-1α induced NO production
and percentage of apoptotic bovine cells (P0.001;
r=0.68).
Only high concentrations of TNF-α induced NO produc-
tion up to 31±8 µmol/L (P0.01), whereas IFN-γ, IL-4 and
IL-6 did not [Fig. 1(d)].
CHONDROCYTE PREINCUBATION WITH IL-4
Viability
Incubation of bovine chondrocytes simultaneously with
100 ng/mL IL-1α and TNF-α did induce a decrease of
viability: 67±2%, compared to control cells (87±3%, P
0.001). Preincubation with IL-4 inhibited this decrease in
viability by 60%, caused by IL-1α and TNF-α: 80±1%
(P0.01). Viability of human chondrocytes incubated with
IL-1α and TNF-α remained unchanged.
Apoptosis
Chondrocytes, pretreated with IL-4 (100 ng/mL), did not
show any difference in percentage apoptotic cells when
incubated with IL-1α and TNF-α [Fig. 3(a and b)].
Proliferation
Preincubation with 100 ng/mL IL-4 inhibited the reduction
in proliferation of IL-1α and TNF-α stimulated chondrocytes
by 30%, compared to cultures with lL1-α and TNF-α alone
(P0.04) [Fig. 3(c)].
NO production
As far as the NO production of chondrocytes was con-
cerned, there was significantly less NO production by IL-4
preincubated bovine chondrocytes, cultured with all con-
centrations of IL-1α and TNF-α, compared to cultures
without preincubation (P0.04; P0.008; P0.002 and
P0.02) [Fig. 3(d)]. NO production of human chondrocytes
preincubated with IL-4 remained unaltered.
Discussion
The present study evaluated the direct influence of one
anti-inflammatory cytokine (IL-4) and a number of pro-
inflammatory cytokines (IL-1α, IL-6, IFN-γ and TNF-α) on
chondrocyte function. Chondrocytes are the only cell
type, present within articular cartilage, responsible for the
production and maintenance of the cartilage matrix.
Pro-inflammatory cytokines, such as IL-1, TNF-α and IFN-γ
have been shown to upregulate the production of matrix
degrading enzymes and to inhibit proteoglycan synthesis,
resulting in loss of cartilage6,11–14. It should be mentioned
that the described anti-inflammatory effects of IL-4 and
IL-13 on cartilage might be indirect since some of these
experiments were performed in vivo allowing complex
interactions with synovial inflammation. In contrast, other
cytokines such as IL-4, IL-10 and IL-13 function mainly as
anti-inflammatory cytokines, having opposite effects on
cartilage metabolism, compared to IL-1, TNF-α and IFN-
γ3,15. In contrast with these previous studies that described
a major role of pro- and anti-inflammatory cytokines
on cartilage synthesis, the influence of IL-4, an anti-
inflammatory cytokine, was investigated on chondro-
cyte survival (viability, apoptosis and proliferation) and
chondrocyte NO production in our study.
Recently, in vivo studies reported a decreased number of
chondrocytes and an increased number of apoptotic
chondrocytes in RA and OA (osteoarthritis) cartilage16–20.
However, it remains unclear which extracellular signals
could stimulate chondrocyte apoptosis in RA, resulting in
cartilage destruction by chondrocyte loss. Clancy et al.
described IL-1 dependent apoptosis of bovine chondro-
cytes exposed to additional oxidant stress21, whereas
others observed TNF-α induced apoptosis in a human
chondrocytic tumor cell line, when pharmacological con-
centrations of 30 ng/mL TNF-α were used or if co-
incubated with chemotherapeutic agents7. PGE2 was also
able to induce apoptosis in bovine chondrocytes22. In our
in vitro study, we could demonstrate that pro-inflammatory
cytokines (IL-1α, TNF-α, IFN-γ) induce apoptosis of bovine
chondrocytes, which might be a mechanism of cartilage
destruction. Whereas very high concentrations (100 ng/mL)
of IL-1α, TNF-α and IFN-γ induced high apoptosis levels up
to 28%, pathophysiological concentrations of IL-1 and
TNF-α, observed in synovial fluid of OA and RA patients
with severe disease activity (1–10 ng/mL)23,24, were also
able to induce low percentages of apoptotic chondrocytes,
which is in accordance with in vivo reported apoptosis
(0.1–3%)16–20. The discrepancies between in vitro and
in vivo number of apoptotic chondrocytes could be ex-
plained by the fact that in vivo chondrocytes die in a context
of cartilage matrix in contrast to in vitro experiments in
Fig. 2. MGG staining of chondrocytes cultured in DMEM 10% FCS for 48 h without (a) and with 100 ng/mL IL-1α (b). Arrows show
representative apoptotic chondrocytes with nuclear condensation. Original magnification ×630.
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which suspensions or monolayers are used. One possibility
is that degradation of extracellular cartilage matrix, in vitro
stimulated by culture of chondrocytes in monolayers, re-
sults in the loss of a survival signal. This may increase the
susceptibility of chondrocytes to undergo apoptosis in
response to pro-inflammatory cytokines as shown in our
study. An important drawback of this study is that most data
were obtained from bovine cartilage. It should be noticed
that TNF and IL-1 were not shown to induce apoptosis in
human articular chondrocytes8. Moreover, in an additional
experiment in human chondrocytes, we were unable to
induce apoptosis by anti-Fas. In a recent review, Aigner
and Kim reported that direct induction of Fas-mediated
apoptosis in cultured chondrocytes is not without contro-
versy25. These facts confirm that one always needs to
carefully consider cell type and culture conditions in the
interpretation of data.
In this study, the positive correlation between NO produc-
tion and the percentage of apoptotic chondrocytes
suggests a role of NO in cytokine-induced apoptosis. NO
has been found to induce apoptosis of various cell types
by decreasing mitochondrial membrane potential, thereby
releasing cytochrome c and activating the caspase
cascade26–28. Blanco et al. showed that exogenously
administered NO induced apoptosis of chondrocytes8. Our
in vitro study provides arguments for endogenously NO-
mediated apoptosis. Apart from this effect, NO can induce
suppression of collagen and proteoglycan synthesis, up-
regulation of metalloproteinases, increased susceptibility to
injury by other oxidants (e.g., H2O2) and inhibition of actin
polymerization8,21,29–32.
In our study, no effect of IL-6 could be demonstrated on
chondrocyte function with respect to chondrocyte apopto-
sis, viability, proliferation and NO production. This is in
accordance with several reports demonstrating that IL-6
does not stimulate the production of collagenase nor does
it modulate the stimulating effects of IL-1β on the produc-
tion of metalloproteinase33–35. In contrast, IL-4 is known
to inhibit Th1 cytokine activity, reduce pro-inflammatory
cytokine production, suppress cartilage degradation
enzymes, upregulate inhibitors of these enzymes and
induce matrix synthesis3. In our in vitro study, a pharmaco-
logical concentration of 100 ng/mL IL-4 was needed to
prevent part of the damage (proliferation and viability
decrease and NO production) caused by IL-1α and TNF-α.
However, no effect on apoptosis was seen. These results
are in accordance with Nishisaka et al. who reported an
inhibition of IL-1 induced NO production by IL-4 in bovine
chondrocytes36. Although anti-inflammatory cytokines are
present in the synovial fluid of RA patients23,24, their levels
are obviously too low to neutralize the deleterious effects of
pro-inflammatory cytokines. Moreover, recently an interest-
ing paper was published37 describing that human primary
chondrocytes do not respond to IL-4. These authors
Fig. 3. Apoptosis, proliferation and NO production of chondrocytes incubated for 48 h with IL-1α and TNF-α (0.1, 1, 10, 100 ng/mL) with (j)
and without (M) preincubation with 100 ng/mL IL-4. Untreated chondrocytes, incubated in culture medium without cytokines, are represented
as 0 ng/mL. (a) Percentage of annexin-V positive, PI negative apoptotic cells. (b) Percentage of TUNEL positive apoptotic cells. (c)
Proliferation of cells, measured as counts per minute (cpm). (d) µmol/L NO, measured by Griess reaction. Results are expressed as mean
(±S.E.M.) of three experiments. *P<0.05 vs chondrocytes without preincubation with IL-4.
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elegantly demonstrated that only dedifferentiated human
chondrocytes showed an IL-4 induced inhibition of IL-1
induced NO production. Indeed, in an additional exper-
iment performed on normal and osteoarthritic human
chondrocytes, we could not find any effect of IL-4 on IL-1
and TNF induced NO production.
In conclusion, pro-inflammatory cytokines such as IL-1
and TNF-α but not IL-6 are able to induce NO-mediated
apoptosis, whereas only high levels of IL-4 can inhibit
the effect of IL-1α and TNF-α on NO production and
proliferation of bovine chondrocytes but not on apoptosis.
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